NCT04016584View on ClinicalTrials.gov

Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

February 25, 2020

Study Completion Date

February 25, 2020

Conditions
Type2 Diabetes
Interventions
BEHAVIORAL

Diabetes Pueblo

These adults will receive diabetes education, the Diabetes Pueblo Program, and will complete Curriculum (A), Diabetes Fundamentals, and Curriculum (B), Insulin Success.

Trial Locations (1)

93463

Sansum Diabetes Research Institute, Santa Barbara

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Sansum Diabetes Research Institute

OTHER

NCT04016584 - Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy | Biotech Hunter | Biotech Hunter